Literature DB >> 8069572

Liposomal (MLV) polymyxin B: physicochemical characterization and effect of surface charge and drug association.

S M Lawrence1, H O Alpar, S M McAllister, M R Brown.   

Abstract

Neutral and charged large vortexed multilamellar hydrogenated egg phosphatidylcholine liposomes containing the polycationic antibiotic polymyxin B (PXB) were characterized with respect to lipid-drug interactions (differential scanning calorimetry), surface charge (zeta potential analysis), size (photon correlation spectroscopy) and morphology (transmission electron microscopy). These physicochemical results will be used to develop a liposomal drug delivery system for PXB that may be useful in the clinical treatment of lung infection in cystic fibrosis patients. The liposomal morphology and membrane integrity of all the preparations were unaffected by associated antibiotic. Drug encapsulation increased in the order neutral = positive < negative, the negatively charged liposomes increasing drug association 2-fold. The phase transition temperature of neutral and positive liposomes was not significantly affected by PXB. Drug-loaded negative liposomes showed a decreased phase transition possibly due to attractive electrostatic interactions between drug and lipid that tended to increase drug penetration and destabilize the liposome bilayer. Drug loading did not affect liposome size. However, both empty and loaded negative liposomes were significantly smaller (approx. 1 micron) than neutral and positive (approx. 2.5 microns) liposomes. Increased encapsulation with negative liposomes is therefore due not to an increase in the entrapped volume but to electrostatic interactions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8069572     DOI: 10.3109/10611869308996088

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  5 in total

1.  Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors.

Authors:  Mai Alhajlan; Moayad Alhariri; Abdelwahab Omri
Journal:  Antimicrob Agents Chemother       Date:  2013-04-01       Impact factor: 5.191

2.  Self-assembly behavior of colistin and its prodrug colistin methanesulfonate: implications for solution stability and solubilization.

Authors:  Stephanie J Wallace; Jian Li; Roger L Nation; Richard J Prankerd; Tony Velkov; Ben J Boyd
Journal:  J Phys Chem B       Date:  2010-04-15       Impact factor: 2.991

3.  Evaluation of the antimicrobial and antioxidant activities of Origanum dictamnus extracts before and after encapsulation in liposomes.

Authors:  Olga Gortzi; Stavros Lala; Ioanna Chinou; John Tsaknis
Journal:  Molecules       Date:  2007-05-02       Impact factor: 4.411

4.  Composite particle formulations of colistin and meropenem with improved in-vitro bacterial killing and aerosolization for inhalation.

Authors:  Sharad Mangal; Heejun Park; Lingfei Zeng; Heidi H Yu; Yu-Wei Lin; Tony Velkov; John A Denman; Dmitry Zemlyanov; Jian Li; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2018-07-03       Impact factor: 5.875

Review 5.  Advances in Lipid and Metal Nanoparticles for Antimicrobial Peptide Delivery.

Authors:  Marcin Makowski; Ítala C Silva; Constança Pais do Amaral; Sónia Gonçalves; Nuno C Santos
Journal:  Pharmaceutics       Date:  2019-11-08       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.